TWST · Twist Bioscience Corp
AI read · Neutral
The AI's read
Anthropic named Twist an independent evaluator in an AI protein-design project and TWST ripped about 20% today while a short-seller called the story a "speculative delusion." The market ignored the short and bid the stock to fresh highs, so the headline clearly moved price. That move looks largely priced in: TWST is up 20.6% today and RSI sits near 72.96, so upside is compressed and sentiment is stretched. The short-seller's claim that Anthropic treated Twist as a service provider raises a real durability question. Our take is neutral. The company got a high-visibility mention, but with the stock frothy and the commercial impact unproven, asymmetric upside looks limited versus downside if Anthropic's role is minor.